Clinical Trial

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Name: A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China — clinical trial record (NCT06588153)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The main objective of this study is to evaluate the efficacy of Prolia® in improving bone mass density (BMD) of lumbar spine at month 12.

Protocol Amendment History 1 change

critical Trial status changed: RECRUITING → ACTIVE_NOT_RECRUITING 2026-05-28

Trial Details

NCT Number	NCT06588153
Lead Sponsor	Amgen
Conditions	Glucocorticoid-induced Osteoporosis
Enrollment	102 participants
Start Date	2025-05-24
Primary Completion	2027-04-27 (estimated)
Study Completion	2027-04-27 (estimated)
Updated on ClinicalTrials.gov	2026-05-27